Stryker Corporation consented to the entry of an order instituting Cease and Desist proceedings for violations of the FCPA’s books and records and internal accounting provisions. Stryker is alleged to have failed to supervise and enforce its anti-corruption policies and code of conduct in the company’s Indian, Chinese, and Kuwaiti subsidiaries. The company will pay a $7.8 million penalty. This is the second time in five years that Stryker has settled FCPA charges.
September 28, 2018
Medical products company settles bribery charges with SEC, again
Related by Topic
US Department of State releases plan to implement the US Strategy on Countering Corruption
September 8, 2023
News Alert
Connecticut oil and gas trader charged with FCPA violations for allegedly bribing Petrobras officials
September 4, 2023
News Alert
DOJ issues first FCPA Opinion Procedure Release of 2023
August 30, 2023
News Alert